Prospective Randomized Trial of Simple Drainage vs. Drainage and Initial Fistula Management for Perianal AbscessesIoannis Galanis*, Grigoris Chatzimavroudis, Petros Christopoulos and John Makris
2nd Surgical Department, School of Medicine, Aristotle University of Thessaloniki, G.Gennimatas General Hospital, Thessaloniki, Greece
- *Corresponding Author:
- Ioannis Galanis
Associate Professor of Surgery
Aristotle university of Thessaloniki
2nd Surgical Department of Surgery
E-mail: [email protected]
Received date: December 28, 2015, Accepted date: January 20, 2016; Published date: January 28, 2016
Citation: Galanis I, Chatzimavroudis G, Christopoulos P, Makris J (2016) Prospective Randomized Trial of Simple Drainage vs. Drainage and Initial Fistula Management for Perianal Abscesses. J Gastrointest Dig Syst 6:382. doi:10.4172/2161-069X.1000382
Copyright: © 2016 Galanis I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background and Aims: Perianal abscess is one of the most frequent proctological disorders and needs urgent treatment. Incision and drainage consists the gold standard therapy of this disorder. However, due to high rates of abscess recurrence, few surgeons favor primary fistula treatment at the time of abscess drainage to decrease the risk of recurrence. This clinical study was designed to compare incision and drainage of perianal abscess with or without fistula treatment. Patients and Methods: Two hundred consecutive patients suffering from acute perianal abscess were prospectively randomized into two groups: group A; treatment of abscess with incision and drainage, group B; incision and drainage plus primary fistula treatment. All patients were followed-up for at least 12 months. Primary endpoints of the study were the rates of abscess recurrence and anal incontinence. Secondary end point was abscess recurrence rate during the overall follow-up period.